Quipt Home Medical Corp Financials

QIPT

Source SEC Filings (10-K/10-Q) Updated Feb 9, 2026 Currency USD FYE September

Financial Health Signals

Financial Profile 37/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Quipt Home Medical Corp has an operating margin of -1.6%, meaning the company retains $-2 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is down from 0.4% the prior year.

Growth

Quipt Home Medical Corp's revenue declined 0.2% year-over-year, from $245.9M to $245.4M. This contraction results in a growth score of 28/100.

Leverage

Quipt Home Medical Corp carries a low D/E ratio of 0.78, meaning only $0.78 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 82/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Quipt Home Medical Corp's current ratio of 1.05 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 22/100, which could limit financial flexibility.

Cash Flow

Quipt Home Medical Corp has a free cash flow margin of 10.3%, earning a moderate score of 52/100. The company generates positive cash flow after capital investments, but with room for improvement.

Piotroski F-Score Weak

3/9

Quipt Home Medical Corp passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality Mixed

-3.52x

For every $1 of reported earnings, Quipt Home Medical Corp generates $-3.52 in operating cash flow ($37.7M OCF vs -$10.7M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage At Risk

-0.8x

Quipt Home Medical Corp earns $-0.8 in operating income for every $1 of interest expense (-$3.8M vs $5.1M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

This page shows Quipt Home Medical Corp (QIPT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Export CSV

Key Financial Metrics

Revenue

$245.4M

YoY-0.2%

Quipt Home Medical Corp generated $245.4M in revenue in fiscal year 2025. This represents a decrease of 0.2% from the prior year.

EBITDA

$41.7M

YoY-8.8%

Quipt Home Medical Corp's EBITDA was $41.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 8.8% from the prior year.

Free Cash Flow

$25.3M

YoY+1.1%

Quipt Home Medical Corp generated $25.3M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 1.1% from the prior year.

Net Income

-$10.7M

YoY-58.2%

Quipt Home Medical Corp reported -$10.7M in net income in fiscal year 2025. This represents a decrease of 58.2% from the prior year.

EPS (Diluted)

$-0.24

YoY-50.0%

Quipt Home Medical Corp earned $-0.24 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 50.0% from the prior year.

Cash & Debt

$12.9M

YoY-20.1%

Quipt Home Medical Corp held $12.9M in cash against $87.6M in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

43M

YoY+0.8%

Quipt Home Medical Corp had 43M shares outstanding in fiscal year 2025. This represents an increase of 0.8% from the prior year.

Gross Margin

72.2%

YoY+0.2pp

Quipt Home Medical Corp's gross margin was 72.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.2 percentage points from the prior year.

Operating Margin

-1.6%

YoY-2.0pp

Quipt Home Medical Corp's operating margin was -1.6% in fiscal year 2025, reflecting core business profitability. This is down 2.0 percentage points from the prior year.

Net Margin

-4.4%

YoY-1.6pp

Quipt Home Medical Corp's net profit margin was -4.4% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1.6 percentage points from the prior year.

Return on Equity

N/A

R&D Spending

N/A

Share Buybacks

$130K

Quipt Home Medical Corp spent $130K on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures

$12.4M

YoY+19.8%

Quipt Home Medical Corp invested $12.4M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 19.8% from the prior year.

QIPT Income Statement

Metric	FY25	FY24	FY23
Revenue	$245.4M-0.2%	$245.9M+16.2%	$211.7M
Cost of Revenue	$68.2M-1.1%	$68.9M+19.0%	$57.9M
Gross Profit	$177.2M+0.1%	$177.0M+15.1%	$153.8M
R&D Expenses	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A
Operating Income	-$3.8M-442.9%	$1.1M-60.9%	$2.9M
Interest Expense	$5.1M-4.7%	$5.3M+21.1%	$4.4M
Income Tax	$241K+121.1%	$109K+28.2%	$85K
Net Income	-$10.7M-58.2%	-$6.8M-142.9%	-$2.8M
EPS (Diluted)	$-0.24-50.0%	$-0.16-128.6%	$-0.07

Metric	Q1'26	Q1'25	Q3'25	Q2'25	Q1'24	Q3'24	Q2'24	Q1'23
Revenue	$81K-99.9%	$81.0M+39.0%	$58.3M+1.6%	$57.4M-6.5%	$61.4M+1.0%	$60.8M-0.8%	$61.3M-2.1%	$62.6M
Cost of Revenue	$23K-99.9%	$22.8M+53.1%	$14.9M-1.7%	$15.1M-14.8%	$17.8M+6.4%	$16.7M+0.1%	$16.7M-6.9%	$17.9M
Gross Profit	$58K-99.9%	$58.2M+34.1%	$43.4M+2.8%	$42.2M-3.2%	$43.6M-1.0%	$44.1M-1.2%	$44.6M-0.2%	$44.7M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	$1K-99.9%	$1.0M+156.2%	-$1.8M-82.5%	-$999K-323.0%	$448K+348.0%	$100K-88.9%	$901K-16.2%	$1.1M
Interest Expense	$1.4M0.0%	$1.4M+17.7%	$1.2M-5.8%	$1.3M-1.9%	$1.3M+1.0%	$1.3M-0.8%	$1.3M-4.0%	$1.4M
Income Tax	$25-99.9%	$25K-28.6%	$35K0.0%	$35K+16.7%	$30K	$0-100.0%	$263K+19.5%	$220K
Net Income	$1K+100.1%	-$1.1M+65.2%	-$3.0M+0.6%	-$3.0M-180.6%	-$1.1M+32.1%	-$1.6M-116.0%	-$739K+50.3%	-$1.5M
EPS (Diluted)	$0.02+200.0%	$-0.02+71.4%	$-0.070.0%	$-0.07-133.3%	$-0.03+25.0%	$-0.04-100.0%	$-0.02+50.0%	$-0.04

QIPT Balance Sheet

Metric	FY25	FY24	FY23
Total Assets	$283.3M+14.6%	$247.2M-0.1%	$247.4M
Current Assets	$78.3M+7.2%	$73.1M+11.6%	$65.4M
Cash & Equivalents	$12.9M-20.1%	$16.2M-6.0%	$17.2M
Inventory	$25.6M+23.0%	$20.9M+13.2%	$18.4M
Accounts Receivable	$34.7M+19.2%	$29.1M+12.1%	$26.0M
Goodwill	$61.6M+21.3%	$50.7M-4.0%	$52.8M
Total Liabilities	$171.2M+22.2%	$140.1M-60.9%	$358.5M
Current Liabilities	$74.7M+22.8%	$60.9M+0.5%	$60.6M
Long-Term Debt	$87.6M+15.1%	$76.1M	N/A
Total Equity	$112.1M+4.6%	$107.2M+196.5%	-$111.1M
Retained Earnings	-$181.3M-6.3%	-$170.6M-4.1%	-$163.8M

Metric	Q1'26	Q1'25	Q3'25	Q2'25	Q1'24	Q3'24	Q2'24	Q1'23
Total Assets	$281K-99.9%	$280.7M+18.9%	$236.1M-3.5%	$244.6M+0.8%	$242.8M-1.8%	$247.2M	N/A	N/A
Current Assets	$78K-99.9%	$78.1M+13.7%	$68.7M-8.4%	$75.0M+7.6%	$69.7M-4.6%	$73.1M	N/A	N/A
Cash & Equivalents	$11K-99.9%	$10.5M-6.3%	$11.3M-34.4%	$17.1M+11.0%	$15.5M-4.5%	$16.2M+10.8%	$14.6M-20.3%	$18.3M
Inventory	$27K-99.9%	$26.9M+12.2%	$24.0M+5.1%	$22.8M+13.8%	$20.1M-3.8%	$20.9M	N/A	N/A
Accounts Receivable	$35K-99.9%	$34.9M+29.3%	$27.0M-8.4%	$29.5M+6.7%	$27.6M-5.1%	$29.1M	N/A	N/A
Goodwill	$62K-99.9%	$61.6M+21.3%	$50.7M0.0%	$50.7M0.0%	$50.7M0.0%	$50.7M	N/A	N/A
Total Liabilities	$168K-99.9%	$167.7M+25.5%	$133.6M-5.3%	$141.1M+3.4%	$136.5M-2.5%	$140.1M	N/A	N/A
Current Liabilities	$75K-99.9%	$75.2M+25.7%	$59.8M-2.4%	$61.3M+7.5%	$57.1M-6.2%	$60.9M	N/A	N/A
Long-Term Debt	$84K-99.9%	$84.0M+27.2%	$66.0M-7.6%	$71.5M+1.2%	$70.6M-7.2%	$76.1M	N/A	N/A
Total Equity	$113K-99.9%	$113.0M+10.2%	$102.5M-1.0%	$103.6M-2.6%	$106.3M-0.8%	$107.2M-2.9%	$110.3M-0.2%	$110.6M
Retained Earnings	$182K+100.1%	-$182.3M-2.6%	-$177.7M-1.7%	-$174.7M-1.8%	-$171.7M-0.6%	-$170.6M	N/A	N/A

QIPT Cash Flow Statement

Metric	FY25	FY24	FY23
Operating Cash Flow	$37.7M+6.5%	$35.4M-4.3%	$37.0M
Capital Expenditures	$12.4M+19.8%	$10.3M+50.5%	$6.9M
Free Cash Flow	$25.3M+1.1%	$25.1M-16.8%	$30.1M
Investing Cash Flow	-$32.9M-219.5%	-$10.3M+87.5%	-$82.8M
Financing Cash Flow	-$7.8M+70.3%	-$26.1M-148.0%	$54.4M
Dividends Paid	N/A	N/A	N/A
Share Buybacks	$130K	N/A	N/A

Metric	Q1'26	Q1'25	Q3'25	Q2'25	Q1'24	Q3'24	Q2'24	Q1'23
Operating Cash Flow	$9K-99.9%	$8.9M-7.5%	$9.7M+8.1%	$8.9M-3.8%	$9.3M-6.8%	$10.0M+132.6%	$4.3M-59.6%	$10.6M
Capital Expenditures	$2K-99.9%	$2.1M-60.4%	$5.2M+225.1%	$1.6M-56.2%	$3.7M+6.4%	$3.5M+192.1%	$1.2M-24.6%	$1.6M
Free Cash Flow	$7K-99.9%	$6.9M+55.0%	$4.4M-39.6%	$7.3M+30.5%	$5.6M-13.8%	$6.5M+109.9%	$3.1M-65.6%	$9.0M
Investing Cash Flow	$2K+100.1%	-$1.9M+55.7%	-$4.4M-180.1%	-$1.6M+57.0%	-$3.6M-8.5%	-$3.4M-182.1%	-$1.2M+27.0%	-$1.6M
Financing Cash Flow	$9K+100.1%	-$9.4M+19.9%	-$11.8M-106.7%	-$5.7M-3.2%	-$5.5M-9.7%	-$5.0M+23.2%	-$6.6M+19.6%	-$8.2M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

QIPT Financial Ratios

Metric	FY25	FY24	FY23
Gross Margin	72.2%+0.2pp	72.0%-0.7pp	72.7%
Operating Margin	-1.6%-2.0pp	0.4%-0.9pp	1.4%
Net Margin	-4.4%-1.6pp	-2.8%-1.4pp	-1.3%
Return on Equity	N/A	N/A	N/A
Return on Assets	-3.8%-1.0pp	-2.7%-1.6pp	-1.1%
Current Ratio	1.05-0.2	1.20+0.1	1.08
Debt-to-Equity	0.78+0.1	0.71+3.9	-3.23
FCF Margin	10.3%+0.1pp	10.2%-4.0pp	14.2%

Metric	Q1'26	Q1'25	Q3'25	Q2'25	Q1'24	Q3'24	Q2'24	Q1'23
Gross Margin	71.9%0.0pp	71.9%-2.6pp	74.5%+0.9pp	73.6%+2.6pp	71.0%-1.5pp	72.5%-0.3pp	72.8%+1.4pp	71.4%
Operating Margin	1.3%0.0pp	1.3%+4.4pp	-3.1%-1.4pp	-1.7%-2.5pp	0.7%+0.6pp	0.2%-1.3pp	1.5%-0.3pp	1.7%
Net Margin	1.3%+2.6pp	-1.3%+3.9pp	-5.2%+0.1pp	-5.3%-3.5pp	-1.8%+0.9pp	-2.6%-1.4pp	-1.2%+1.2pp	-2.4%
Return on Equity	0.9%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	0.4%+0.8pp	-0.4%+0.9pp	-1.3%-0.0pp	-1.2%-0.8pp	-0.4%	N/A	N/A	N/A
Current Ratio	1.040.0	1.04-0.1	1.15-0.1	1.220.0	1.22+0.0	1.20	N/A	N/A
Debt-to-Equity	0.740.0	0.74+0.1	0.64-0.0	0.69+0.0	0.66-0.0	0.71	N/A	N/A
FCF Margin	8.5%0.0pp	8.5%+0.9pp	7.6%-5.2pp	12.8%+3.6pp	9.2%-1.4pp	10.5%+5.5pp	5.1%-9.4pp	14.4%

Similar Companies

$178.4M

$68.0M

$3.8M

$216.6M

Synergy Chc Corp SNYR

$18.6M

Frequently Asked Questions

What is Quipt Home Medical Corp's annual revenue?

Quipt Home Medical Corp (QIPT) reported $245.4M in total revenue for fiscal year 2025. This represents a -0.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Quipt Home Medical Corp's revenue growing?

Quipt Home Medical Corp (QIPT) revenue declined by 0.2% year-over-year, from $245.9M to $245.4M in fiscal year 2025.

Is Quipt Home Medical Corp profitable?

No, Quipt Home Medical Corp (QIPT) reported a net income of -$10.7M in fiscal year 2025, with a net profit margin of -4.4%.

What is Quipt Home Medical Corp's earnings per share (EPS)?

Quipt Home Medical Corp (QIPT) reported diluted earnings per share of $-0.24 for fiscal year 2025. This represents a -50.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is Quipt Home Medical Corp's EBITDA?

Quipt Home Medical Corp (QIPT) had EBITDA of $41.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Quipt Home Medical Corp have?

As of fiscal year 2025, Quipt Home Medical Corp (QIPT) had $12.9M in cash and equivalents against $87.6M in long-term debt.

What is Quipt Home Medical Corp's gross margin?

Quipt Home Medical Corp (QIPT) had a gross margin of 72.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Quipt Home Medical Corp's operating margin?

Quipt Home Medical Corp (QIPT) had an operating margin of -1.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Quipt Home Medical Corp's net profit margin?

Quipt Home Medical Corp (QIPT) had a net profit margin of -4.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Quipt Home Medical Corp's free cash flow?

Quipt Home Medical Corp (QIPT) generated $25.3M in free cash flow during fiscal year 2025. This represents a 1.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Quipt Home Medical Corp's operating cash flow?

Quipt Home Medical Corp (QIPT) generated $37.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Quipt Home Medical Corp's total assets?

Quipt Home Medical Corp (QIPT) had $283.3M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Quipt Home Medical Corp's capital expenditures?

Quipt Home Medical Corp (QIPT) invested $12.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Quipt Home Medical Corp buy back shares?

Yes, Quipt Home Medical Corp (QIPT) spent $130K on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Quipt Home Medical Corp have outstanding?

Quipt Home Medical Corp (QIPT) had 43M shares outstanding as of fiscal year 2025.

What is Quipt Home Medical Corp's current ratio?

Quipt Home Medical Corp (QIPT) had a current ratio of 1.05 as of fiscal year 2025, which is considered adequate.

What is Quipt Home Medical Corp's debt-to-equity ratio?

Quipt Home Medical Corp (QIPT) had a debt-to-equity ratio of 0.78 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Quipt Home Medical Corp's return on assets (ROA)?

Quipt Home Medical Corp (QIPT) had a return on assets of -3.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Quipt Home Medical Corp's Piotroski F-Score?

Quipt Home Medical Corp (QIPT) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Quipt Home Medical Corp's earnings high quality?

Quipt Home Medical Corp (QIPT) has an earnings quality ratio of -3.52x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Quipt Home Medical Corp cover its interest payments?

Quipt Home Medical Corp (QIPT) has an interest coverage ratio of -0.8x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Quipt Home Medical Corp?

Quipt Home Medical Corp (QIPT) scores 37 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.